Tag: Screening

Kits were developed and distributed in the early weeks of the pandemic when no other authorized tests were available

Diagnostic yields were higher for disorders likely to have a monogenic cause versus those with a complex cause

Prostate-specific antigen testing rates increased for men aged 40 to 89 years following 2017 revision of USPSTF recommendation on screening

Not clear whether the new, tougher rule will require an antigen or rapid PCR test

Cumulative live-birth rate with use of conventional IVF noninferior to that for embryo selection with preimplantation genetic testing for aneuploidy

In post-COVID-19 peak period in 2020, CT volume still down for cancer screening and initial workup with inconsistent recovery for active cancer

Darker skin types underrepresented among publicly available skin image datasets used to inform skin cancer diagnosis

Among participants in a biobank found to be carrying pathogenic or likely pathogenic variants, 76.3 percent unaware of these research results

35 reports of false-positive results sent to the FDA, but no deaths have been reported

Screening efforts should be focused on populations at high risk based on age of housing, sociodemographic risk factors